CSIMarket
 

Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Pra Health Sciences Inc 's

Competitiveness




 

PRAH Sales vs. its Competitors Q1 2021



Comparing the current results to its competitors, Pra Health Sciences Inc reported Revenue increase in the 1 quarter 2021 by 19.15 % year on year.
The sales growth was above Pra Health Sciences Inc 's competitors' average revenue growth of 10.88 %, achieved in the same quarter.

List of PRAH Competitors

With a net margin of 6.1 % Pra Health Sciences Inc achieved higher profitability than its competitors.

More on PRAH Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Pra Health Sciences Inc Net Income in the 1 quarter 2021 grew year on year by 40.04%, faster than the Pra Health Sciences Inc 's competitors average income growth of 34.58 %

<<  PRAH Stock Performance Comparisons



  

Overall company Market Share Q1 2021

Overall company sales advanced by 19.15 % Pra Health Sciences Inc outperformed its competitors in this segment and improved market share, to approx. 38.67 %.
<<  More on PRAH Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Pra Health Sciences Inc




Medpace Holdings Inc
Share Performance



+2.09%
30 Days



Medpace Holdings Inc
Profile

Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.

More about Medpace Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 16,712.656 mill. $ 2,782.288 mill. $ 491.500 mill.


Science 37 Holdings Inc
Share Performance



+12.75%
This Year



Science 37 Holdings Inc
Profile

Science 37 Holdings Inc's business model revolves around providing a virtual clinical trial operating system that facilitates remote patient participation in clinical research studies.

More about Science 37 Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 679.340 mill. $ 60.261 mill. $ -110.729 mill.


Syneos Health Inc
Share Performance



+18.30%
This Year



Syneos Health Inc
Profile

Syneos Health Inc's business model revolves around offering end-to-end solutions in the pharmaceutical and biotechnology industry. They provide a comprehensive range of services, including clinical research, commercialization, consulting, and technology solutions to help clients accelerate the development and delivery of innovative therapies. By integrating various aspects of the industry, Syneos Health aims to improve efficiency, drive productivity, and ultimately support the success of their clients' healthcare products.

More about Syneos Health Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,484.705 mill. $ 5,418.970 mill. $ 71.221 mill.

Sources: Pra Health Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Pra Health Sciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.